| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |